Targeted inhibition of the phosphoinositide 3-kinase impairs cell proliferation, survival, and invasion in colon cancer

References

• DaviesJMGoldbergRMTreatment of metastatic colorectal cancerSemin Oncol20113855256021810514
   PubMedGoogle Scholar
• ChenJPotential value and limitation of dual inhibitors of PI3K and mTOR in the treatment of cancerCurr Cancer Drug Targets20131311712023215718
   PubMedGoogle Scholar
• BuZJiJTherapeutic implications of mTOR inhibitors in the treatment of gastric cancerCurr Cancer Drug Targets20131312112523215721
   PubMed Web of Science ®Google Scholar
• ChoDCMierJWDual inhibition of PI3-kinase and mTOR in renal cell carcinomaCurr Cancer Drug Targets20131312614223259857
   PubMedGoogle Scholar
• ElfikyAAJiangZThe PI3 kinase signaling pathway in prostate cancerCurr Cancer Drug Targets20131315716423215719
   PubMedGoogle Scholar
• YuYYuXMaJTongYYaoJEffects of NVP-BEZ235 on the proliferation, migration, apoptosis and autophagy in HT-29 human colorectal adenocarcinoma cellsInt J Oncol20164928529327176231
   PubMed Web of Science ®Google Scholar
• ChenJIversonDEstrogen in obesity-associated colon cancer: friend or foe? Protecting postmenopausal women but promoting late-stage colon cancerCancer Causes Control2012231767177323011535
   PubMedGoogle Scholar
• WangHZhangLYangXPUMA mediates the combinational therapy of 5-FU and NVP-BEZ235 in colon cancerOncotarget20156143851439825965911
   PubMedGoogle Scholar
• WuDChengJSunGp70S6K promotes IL-6-induced epithelial-mesenchymal transition and metastasis of head and neck squamous cell carcinomaOncotarget20167365393655027174914
   PubMedGoogle Scholar
• SegattoIBertonSSonegoMp70S6 kinase mediates breast cancer cell survival in response to surgical wound fluid stimulationMol Oncol2014876678024661902
   PubMedGoogle Scholar
• JiYDiWYangQLuZCaiWWuJInhibition of autophagy increases proliferation inhibition and apoptosis induced by the PI3K/mTOR inhibitor NVP-BEZ235 in breast cancer cellsClin Lab2015611043105126427150
   PubMedGoogle Scholar
• LiCXinPXiaoHYanZHuangYZhuXThe dual PI3K/mTOR inhibitor NVP-BEZ235 inhibits proliferation and induces apoptosis of burkitt lymphoma cellsCancer Cell Int2015156526130968
   PubMed Web of Science ®Google Scholar
• MairaSMStaufferFBrueggenJIdentification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activityMol Cancer Ther200871851186318606717
   PubMed Web of Science ®Google Scholar
• WangWLongLYangNNVP-BEZ235, a novel dual PI3K/mTOR inhibitor, enhances the radiosensitivity of human glioma stem cells in vitroActa Pharmacol Sin20133468169023603977
   PubMed Web of Science ®Google Scholar
• RoperJRichardsonMPWeiVWThe dual PI3K/mTOR inhibitor NVP-BEZ235 induces tumor regression in a genetically engineered mouse model for sporadic colorectal cancerGastroenterology20116e25132
   Google Scholar
• ChenJShaoRLiFPI3K/Akt/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cellsClin Exp Pharmacol Physiol20164213171326
   Google Scholar
• YanFShaoLJHuXYKnockdown of UHRF1 by lentivirus-mediated shRNA inhibits ovarian cancer cell growthAsian Pac J Cancer Prev2015161343134825743796
   PubMedGoogle Scholar
• HabibRAkhtarJTaqiMYuCZhangCLentiviral vector-mediated survivin shRNA delivery in gastric cancer cell lines significantly inhibits cell proliferation and tumor growthOncol Rep20153485926043753
   PubMedGoogle Scholar
• GayatriDVBadanaATherapeutic Potentials of CD151 shRNA in Targeting Metastasis of Triple Negative Breast Cancer Cell Line MDA-MB-231J Cancer Sci Ther20168104112
   Google Scholar
• DangNPangSSongHAnLMaXInactivation of mitogen-activated protein kinase signaling pathway reduces caspase-14 expression in impaired keratinocytesIran J Basic Med Sci201619283327096061
   PubMedGoogle Scholar
• CatalanoVDiFSIovinoFDieliFStassiGTodaroMCD133 as a target for colon cancerExpert Opin Ther Targets20121625926722385077
   PubMed Web of Science ®Google Scholar
• ChenJHuangXFQiaoLKatsifisAInsulin caused drug resistance to oxaliplatin in colon cancer cell HT29J Gastrointest Oncol20112273322811824
   PubMedGoogle Scholar
• DallasNALingXFanFChemoresistant colorectal cancer cells, the cancer stem cell phenotype and increased sensitivity to insulin-like growth factor receptor-1 inhibitionCancer Res2009691951195719244128
   PubMed Web of Science ®Google Scholar
• DuronioVThe life of a cell: apoptosis regulation by the PI3K/PKB pathwayBiochem J200841533334418842113
   PubMed Web of Science ®Google Scholar
• SabatiniDMSarbassovDDPhosphorylation and regulation of Akt/PKB by the rictor-mTOR complexAm Assoc Advanc Sci201110981101
   Google Scholar
• RoyHKOlusolaBFClemensDLAKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesisCarcinogenesis20022320111756242
   PubMed Web of Science ®Google Scholar
• CourtneyKDCorcoranRBEngelmanJAThe PI3K pathway as drug target in human cancerJ Clin Oncol2010281075108320085938
   PubMed Web of Science ®Google Scholar
• FumarolaCBonelliMAPetroniniPGAlfieriRRTargeting PI3K/AKT/mTOR pathway in non small cell lung cancerBiochem Pharmacol20149019720724863259
   PubMed Web of Science ®Google Scholar
• Moon DuGLeeSEOHMMNVP-BEZ235, a dual PI3K/mTOR inhibitor synergistically potentiates the antitumor effects of cisplatin in bladder cancer cellsInt J Oncol2014451027103524969552
   PubMed Web of Science ®Google Scholar
• GarciaJADanielpourDMammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignanciesMol Cancer Ther200871347135418566209
   PubMed Web of Science ®Google Scholar
• CebullaJHuuseEMPettersenKMRI reveals the in vivo cellular and vascular response to BEZ235 in ovarian cancer xenografts with different PI3-kinase pathway activityBr J Cancer201511250451325535727
   PubMedGoogle Scholar
• DanielsenSAEidePWNesbakkenAGurenTLeitheELotheRAPortrait of the PI3K/AKT pathway in colorectal cancerBiochim Biophys Acta2015185510412125450577
   PubMed Web of Science ®Google Scholar
• Papadatos-PastosDRabbieRRossPSarkerDThe role of the PI3K pathway in colorectal cancerCrit Rev Oncol Hematol201594183025591826
   PubMed Web of Science ®Google Scholar
• HongSWShinJSMoonJHNVP-BEZ235, a dual PI3K/mTOR inhibitor, induces cell death through alternate routes in prostate cancer cells depending on the PTEN genotypeApoptosis20141989524652480
   PubMed Web of Science ®Google Scholar
• HongZLiLCarcedoIGZhiPXMonteiroMGuWSynergistic inhibition of colon cancer cell growth with nanoemulsion-loaded paclitaxel and PI3K/mTOR dual inhibitor BEZ235 through apoptosisInt J Nanomedicine2016111947195827226714
   PubMedGoogle Scholar
• CakirEYilmazADemiragFPrognostic significance of micropapillary pattern in lung adenocarcinoma and expression of apoptosis-related markers: caspase-3, bcl-2, and p53APMIS201111957458021851414
   PubMed Web of Science ®Google Scholar
• MallaRRGopinathSAlapatiKGorantlaBGondiCSRaoJSuPAR and cathepsin B inhibition enhanced radiation-induced apoptosis in glioma initiating cellsNeuro Oncol20121474576022573309
   PubMedGoogle Scholar
• SoaresNDCPTeodoroAJOliveiraFLLycopene induce apoptosis in human prostate cells and alters the expression of Bax and Bcl-2 genesLWT Food Sci Technol20145912901297
   Google Scholar
• LiuGWangTWangTSongJZhouZEffects of apoptosis-related proteins caspase-3, Bax and Bcl-2 on cerebral ischemia ratsBiomed Rep2013186186724649043
   PubMedGoogle Scholar
• O’ConnorLHuangDCO’ReillyLAStrasserAApoptosis and cell division: commentaryCurr Opin Cell Biol20001225726310819542
   PubMed Web of Science ®Google Scholar